50.40MMarket Cap-1276P/E (TTM)
4.830High4.120Low81.36KVolume4.320Open4.310Pre Close358.40KTurnover1.37%Turnover RatioLossP/E (Static)10.77MShares11.45052wk High10.35P/B27.77MFloat Cap2.96052wk Low--Dividend TTM5.93MShs Float263.000Historical High--Div YieldTTM16.47%Amplitude2.960Historical Low4.405Avg Price1Lot Size
Elicio Therapeutics Stock Forum
NEWS
Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
Elicio Therapeutics revealed preliminary data from their AMPLIFY-7P Phase 1a study of ELI-002 7P at the ASCO 2024 Annual Meeting. The cancer vaccine candidate, targeting mKRAS-driven solid tumors, showed promising results. ELI-002 7P was well tolerated and induced a significant (~100x...
No comment yet